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hypnotic agent. Its most notorious adverse effect,
although rare, is propofol infusion syndrome (PRIS). It
manifests as acute cardio-circulatory failure, severe
rhabdomyolysis, and acute kidney injury (AKI), which
result in a very high mortality.1 In this paper, we present a
case of refractory status epilepticus in association with
PRIS. Combined management using extracorporeal mem-
brane oxygenation (ECMO) and high cut-off filter withConflicts of interest: The authors have no conflicts of interest
relevant to this article.
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dialysis (SLED)] successfully reversed the severe cardio-
vascular failure and AKI.
A 41-year-old man had a history of febrile encephalop-
athy at age 3 months with the sequela of generalized ton-
iceclonic seizures. He presented to the emergency room
for frequent seizures. Brain computed tomography imaging
with contrast showed normal results. Chest x-ray revealed
aspiration pneumonia. However, the seizure persisted,
despite lorazepam injections and administering multiple
antiepileptic drugs. Based on the impression of status epi-
lepticus, a continuous infusion of midazolam, and later
propofol, were added. The next day, burst-suppressed ac-
tivity on the electroencephalogram was achieved after
gradually titrating the propofol dosage to a maximum of
6.0 mg/kg/h.
Acute hypotension with tachycardia unfortunately
developed after 65 hours of propofol infusion. Blood
biochemistry revealed elevated amylase, lipase, creatine
kinase, and lactic acidosis. Propofol was discontinued
immediately because of a high suspicion of PRIS. AcuteAssociation. All rights reserved.
Table 1 Time series in the course of treatment and laboratory changes after admission.
Time Day 1 Day 3 Day 6 Day 10 Day 14 Day 30
Event Frequent GTC, intubation,
and admission
Start propofol
infusion
PRIS and the onset
of ECMO and SLED
Wean from
ECMO
Wean from
SELD
CK (U/L) 63 X >300,000 54,690 1281 82
BUN (mg/dL) 8 8 12 7 30 67
Cre (mg/dL) 1.09 1.16 3.13 0.89 1.91 1.15
AST (mg/dL) 19 X 2318 1620 269 72
eGFR 78.9 73.4 23.3 99.6 41.3 74.1
AST Z aspartate aminotransferase; BUN Z blood urea nitrogen; CK Z creatine kinase; Cre Z creatinine; ECMO Z extracorporeal
membrane oxygenation; eGFRZ estimated glomerular filtration rate; GTCZ generalized tonic-clonic seizure; PRISZ propofol infusion
syndrome; SLED Z sustained low-efficiency dialysis; X Z not checked at that time point.
1146 Y.-T. Fang et al.shock developed and did not respond to high doses of
inotropic agents and fluid supplementation.
Venous-arterial type ECMO support was initiated. On the
same day, continuouseSLED-diafiltration was also initiated
for acute oliguria and high levels of circulating creatine
kinase (CK). A high-flux dialyzer (FX 60 class, Helixone;
Fresenius Medical Care Taiwan Co. Ltd., Taipei, Taiwan)
was used during the SLED course.
After 4 days maintenance, the patient was removed
from ECMO support. Seven days later, the CK levels
decreased significantly from a high of >300,000 IU/L to
1281 IU/L under the regular daily program of SLED
(Table 1). His neurological status recovered to baseline with
no need for ventilator support or dialysis at discharge.
A review of the literature yielded three cases of PRIS in
which EMCO resuscitation was successfully used to allow
time for the patient to recover.2,3 All patients were ado-
lescents or children (age, <18 years old). To the best of our
knowledge, we are the first to report a positive role of
ECMO in an adult patient with PRIS.
Another crucial issue in patients with PRIS is AKI asso-
ciated with severe rhabdomyolysis. Renal replacement
therapy is usually required during the management of pa-
tients with PRIS, especially during the course of ECMO
support.4 However, conventional renal replacement ther-
apy does not effectively remove myoglobin because of the
size of the molecule.5 In this report, by using an in vivo
molecular cut off of 30 kDa, the high flux polysulfone filters
effectively removed myoglobin (17.8 kDa).
In summary, the combination of ECMO and SLED provided
our patient effective cardiac support and myoglobinclearance, which are the two most complicated issues in
the setting of PRIS. Further studies that involve more pa-
tients with PRIS may corroborate the benefit of this com-
bination strategy.Acknowledgments
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